advertisement

Topcon

de Crom RMPC 10

Showing records 1 to 10 | Display all abstracts from de Crom RMPC

90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
de Crom RMPC
Journal of Glaucoma 2020; 29: 794-798
90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Scheres LMJ; Kujovic-Aleksov S
Acta Ophthalmologica 2021; 99: e433-e440
90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Slangen CGMM
Journal of Glaucoma 2020; 29: 794-798
90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Kujovic-Aleksov S; Ramdas WD
Acta Ophthalmologica 2021; 99: e433-e440
90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Kujovic-Aleksov S; Kujovic-Aleksov S; Webers CAB
Journal of Glaucoma 2020; 29: 794-798
90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
de Crom RMPC
Acta Ophthalmologica 2021; 99: e433-e440
90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Berendschot TTJM
Journal of Glaucoma 2020; 29: 794-798
90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Roelofs LCG; Berendschot TTJM
Acta Ophthalmologica 2021; 99: e433-e440
90044 Micropulse Trans-scleral Cyclophotocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes
Beckers HJM
Journal of Glaucoma 2020; 29: 794-798
90568 XEN Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results
Webers CAB; Beckers HJM
Acta Ophthalmologica 2021; 99: e433-e440

Issue 21-3

Change Issue


advertisement

Topcon